Product Name: Human TFPI Antibody (Concizumab, Research Use)
Catalog Number: NBR-0554
Target Name: TFPI
Trade Name: Concizumab
Antibody Drug Description: Concizumab is an anti-TFPI monoclonal antibody, designed to block a protein in the body that stops blood from clotting, called TFPI. By blocking TFPI, concizumab encourages the production of a blood clotting protein called thrombin, which helps to clot the blood and prevent bleeding. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name:  TFPI
Synonyms: EPI; LACI; TFI; TFPI1
Target Description: Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex.
Ensembl: ENSG00000003436
Uniprot:  P10646